| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/21/2004 | EP1438331A1 A novel modulator of non-genonic activity of nuclear receptors (mnar) and uses thereof |
| 07/21/2004 | EP1438068A2 Antibody inhibitors of gdf-8 and uses thereof |
| 07/21/2004 | EP1438067A1 Autologous growth factor cocktail composition, method of production and use |
| 07/21/2004 | EP1268833B1 Modified nodavirus rna for gene delivery |
| 07/21/2004 | EP0815224B1 Receptor activation by gas6 |
| 07/21/2004 | EP0767176B1 Novel glyceroglycophospholipid, antibody there against, and method of detecting mycoplasma |
| 07/21/2004 | EP0635030B1 IMMUNOTOXINS DIRECTED AGAINST c-erbB-2 (HER-2/neu) RELATED SURFACE ANTIGENS |
| 07/21/2004 | CN1514881A Enzymatic coupling of L-phenylalanine methyl ester and N-benzyloxycarbonyl-L-aspartic acid in continuous or fed-batch process |
| 07/21/2004 | CN1514880A Method and compositions for making emamectin |
| 07/21/2004 | CN1514879A Moraxella (branhamella) catarrhalis antigens |
| 07/21/2004 | CN1514844A Modified granulocyte colony stimulating factor (G-CSF) with reduced immunogenicity |
| 07/21/2004 | CN1514733A Modified erythropoietin (EPO) with reduced immunogenicity |
| 07/21/2004 | CN1514009A 鸡蛋小肽 Eggs small peptides |
| 07/21/2004 | CN1513997A Method of detecting 5'-methioadenosine phosphorylase defect type mammarian cell |
| 07/21/2004 | CN1513995A Pleiomorphic saccharomyces hansenii expression recombination cholere toxin B subunit gene and its application |
| 07/21/2004 | CN1513979A High efficiency expression of recombination human bone forming protein 4 and 7 in methanol yeast |
| 07/21/2004 | CN1513874A Human source anti SARS coronavirus gene engineering antibody |
| 07/21/2004 | CN1513873A Nucleic acid, expression carrier and application of steady wheat high molecular gluten Dtx1, 5 subunit coding gene |
| 07/21/2004 | CN1513481A Method for preparing non-specific immunity activator |
| 07/21/2004 | CN1158388C Technological process of continuously perfused culture of hybrid tumor cell to prepare antibody |
| 07/21/2004 | CN1158386C Polynucleotides isolated from skin cells and methods for their use |
| 07/21/2004 | CN1158304C Antibacteria frog skin peptide derivative |
| 07/20/2004 | US6765086 Self-aligning peptides modeled on human elastin and other fibrous proteins |
| 07/20/2004 | US6764995 Uses as an inhibitor of endothelial cell proliferation, capable of inhibiting angiogenesis and causing tumor regression |
| 07/20/2004 | US6764853 Method for targeted delivery of nucleic acids |
| 07/20/2004 | US6764827 For detection and measurement of serine proteases found in granulocytes |
| 07/20/2004 | US6764680 Administering monoclonal antibodies |
| 07/20/2004 | US6764679 Preferential protein for use in the diagnosis and treatment of cancers; antitumor agents; anticarcinogeneic agents |
| 07/20/2004 | CA2096159C Peptides that induce antibodies which neutralize genetically divergent hiv-1 isolates |
| 07/15/2004 | WO2004059556A2 Method and device for optimizing a nucleotide sequence for the purpose of expression of a protein |
| 07/15/2004 | WO2004058951A1 Mutations affecting plasmid copy number |
| 07/15/2004 | WO2004058944A2 Product quality enhancement in mammalian cell culture processes for protein production |
| 07/15/2004 | WO2004058800A2 Mammalian cell culture processes for protein production |
| 07/15/2004 | WO2004058799A2 Methods and compositions for inhibiting binding of ige to a high affinity receptor |
| 07/15/2004 | WO2004058147A2 Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof |
| 07/15/2004 | WO2004041076A3 Methods of detecting colorectal cancer |
| 07/15/2004 | WO2004029280A3 Anti-hla assay and methods |
| 07/15/2004 | WO2004020609A3 Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection |
| 07/15/2004 | WO2004019878A3 Adzymes and uses thereof |
| 07/15/2004 | WO2004005478A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/15/2004 | WO2003100022A3 Methods and dna constructs for high yield production of polypeptides |
| 07/15/2004 | WO2003099226A3 Antibody peg positional isomers, compositions comprising same, and use thereof |
| 07/15/2004 | WO2003099209A3 Compositions and methods for screening and identifying anti-hcv agents |
| 07/15/2004 | WO2003093422A3 Novel tissue factor targeted antibodies as anticoagulants |
| 07/15/2004 | WO2003083056A3 Secretion of proteins with multiple disulfide bonds in bacteria and uses thereof |
| 07/15/2004 | WO2003070965A9 The eaat2 promoter and uses thereof |
| 07/15/2004 | WO2003047506A3 Peptide agonists of prostate-specific antigen, and uses therefor |
| 07/15/2004 | WO2003015694A3 Agents for enhancing the immune response |
| 07/15/2004 | WO2002101074A3 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 07/15/2004 | WO2002081636A3 Protein modification and maintenance molecules |
| 07/15/2004 | US20040139501 Expression vector coding linalool synthase (LIS)promoter for use as tool in controlling tissue directed heterologous gene expression in plants; tissue engineering |
| 07/15/2004 | US20040139497 Comprises expression vector coding insecticidal polypeptide for use in generation and propagation of insect resistant plants; boiological pest control |
| 07/15/2004 | US20040138426 Protein recovery |
| 07/15/2004 | US20040138424 Method of purifying protein |
| 07/15/2004 | US20040138420 Fluorescent proteins |
| 07/15/2004 | US20040138416 Comprises membrane protein for use in diagnosis prevention and treatment of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune, inflammatory, metabolic and viral disorders |
| 07/15/2004 | US20040138414 Secreted proteins |
| 07/15/2004 | US20040138130 Active modified hedgehog proteins |
| 07/15/2004 | US20040138126 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 07/15/2004 | US20040138124 immunostimulants used for prophylaxis or prevention diseases related to enzymatic deficiency, to stimulate in vivo hydrolysis of xenobiotics, drugs and toxins, or as antiallergens; metabolic and genetic disorders |
| 07/15/2004 | US20040138117 administering proteins or polypeptides for prophylaxis or diagnosis of nervous system and gastrointerstinal disorders ; genetic engineering; drug screening |
| 07/15/2004 | US20040138106 Glycoprotein synthesis |
| 07/15/2004 | US20040137601 Amino acid sequences for therapeutic and prophylactic use against diseases due to clostridium difficile toxins |
| 07/15/2004 | US20040137591 Alcohol oxidase 1 regulatory nucleotide sequences for heterologous gene expression in yeast |
| 07/15/2004 | US20040137583 high optical density [OD] from the group selected from an algae whose life cycle has sexual/asexual reproduction and vegetative propagation: Galaxaura oblongata, Halymenia ceylanica, Helminthocladia australis, and Porphyra dentata |
| 07/15/2004 | US20040137580 for treating or preventing hyperacute rejection; solid phase synthesis; genetic engineering |
| 07/15/2004 | US20040137579 Protein complexes having factor VIII:C activity and production thereof |
| 07/15/2004 | US20040137573 for drug screening treatments for pain, neuropathy, rheumatoid/osteo arthritis, stroke, inflammation, asthma, allergy, urogenital disorders, incontinence, hypertension, hypotension, perivasular disease; animal models; kits |
| 07/15/2004 | US20040137570 Immunoglobulin 2 |
| 07/15/2004 | US20040137564 for diagnosing, treating, or preventing cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders, and viral infections;solid phase synthesis |
| 07/15/2004 | US20040137562 Genetically-engineered mhc molecules |
| 07/15/2004 | US20040137561 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/15/2004 | US20040137560 comprises rupturing a yeast cell in a frozen state and and mashing in a mortar with a pestle followed by dialysis; kits |
| 07/15/2004 | US20040137559 Process for producing N-formylamino acid and use thereof |
| 07/15/2004 | US20040137558 by using a culture of a microbe having an ability to produce a dipeptide from an amino acid ester and an amino acid |
| 07/15/2004 | US20040137557 Remodeling and glycoconjugation of peptides |
| 07/15/2004 | US20040137530 for diagnostic assays/genetically engineering drugs and vaccines |
| 07/15/2004 | US20040137523 Method of isolation and self-assembly of small protein particles from blood and other biological materials |
| 07/15/2004 | US20040137513 Agonist anti-trk-c monoclonal antibodies |
| 07/15/2004 | US20040137510 by screening genomic DNA for mutations; solid phase synthesis; kits |
| 07/15/2004 | US20040137506 for drug screening compunds that affect inappropriate regulation, development, or physiology of antigen presenting cells |
| 07/15/2004 | US20040137505 for use in cleaning products and detergents |
| 07/15/2004 | US20040137492 Novel polypeptide |
| 07/15/2004 | US20040137450 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 07/15/2004 | US20040137435 Human abc transporter expressed in liver,atil |
| 07/15/2004 | US20040137091 Unhydrolyzed and hydrolyzed jojoba protein having high simmondsin concentration of about 11-18% by weight simmondsin 2-(cyanomethylene)-3-hydroxy-4,5-dimethoxy-cyclohexyl-glucoside); cosmetics;detergents; films; sanitizers shampoos |
| 07/15/2004 | US20040137011 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 07/15/2004 | US20040137001 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 07/15/2004 | US20040137000 deimmunized antibodies derived from mouse monoclonal antibody B4 |
| 07/15/2004 | US20040136997 Identification and development of specific monoclonal antibodies to squamous cell carcinoma |
| 07/15/2004 | US20040136995 antibody, or fragment thereof, that specifically binds an ACT-4-h-1 receptor; has different binding specificity than a monoclonal antibody generated by hybridoma HBL106 |
| 07/15/2004 | US20040136982 Novel monoclonal antibody |
| 07/15/2004 | CA2511520A1 Mammalian cell culture processes for protein production |
| 07/15/2004 | CA2511503A1 Method and device for optimizing a nucleotide sequence for the purpose of expression of a protein |
| 07/15/2004 | CA2509702A1 Mutations affecting plasmid copy number |
| 07/15/2004 | CA2508948A1 Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof |
| 07/15/2004 | CA2489590A1 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/14/2004 | EP1437413A1 Method of expressing genetically modified protein carrying sugar chain having sialic acid added thereto in insect cells |
| 07/14/2004 | EP1437399A1 Yeast extract solution, its preparation and use for cell-free protein synthesis |
| 07/14/2004 | EP1437367A1 Antibody and use thereof |